Last update:

HIV & AIDS news

HIV & AIDS

New mechanism found in statin therapy's heart benefits for HIV

Investigators who previously found that a daily statin pill helps prevent heart attacks and strokes in people with HIV have now discovered a potential mechanism that may help to stabilize plaques and prevent their rupture ...

HIV & AIDS

International study shows updated hepatitis B vaccine more effective for people with HIV

A newer vaccine against hepatitis B virus was clearly superior to an older vaccine type in inducing a protective antibody response among people living with HIV who didn't respond to prior vaccination, according to the results ...

Medical research

HIV: There's hope for a cure—where we stand now

With the help of new scientific and technological developments, the HIV/Aids research community is increasingly turning to an ambitious goal: finding a cure for HIV/Aids.

HIV & AIDS

Considerable scale-up needed to achieve 2025 goals for HIV PrEP

Considerable scale-up is needed to achieve the 2025 goals for HIV preexposure prophylaxis (PrEP), according to research published in the Nov. 28 issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality ...

HIV & AIDS

Why is a cure for HIV so elusive?

Schulich School of Medicine & Dentistry researchers are on the cutting-edge of the study of HIV, working toward treatments and a better understanding of how the virus works.

HIV & AIDS

Fewest new HIV cases since late 1980s: UNAIDS report

Fewer people contracted HIV last year than at any point since the rise of the disease in the late 1980s, the United Nations said Tuesday, warning that this decline was still far too slow.

HIV & AIDS

Study links historical redlining to delays in HIV treatment

A new study from Tulane University finds that historical race-based lending practices are still impacting health today, linking these discriminatory policies to delays in effective HIV treatment within affected neighborhoods.

HIV & AIDS

Survey finds continued declines in HIV clinician workforce

The supply of health care professionals available to provide HIV care continues to decline, even as the need for HIV care and prevention is expected to increase, reports a survey study in the November/December issue of the ...

HIV & AIDS

New gene discovery aids HIV vaccine progress

Continuing their journey to develop a vaccine for HIV, Oregon Health & Science University researchers have identified a gene that could have prevented their vaccine from working in humans.

HIV & AIDS

Success of long-lasting HIV drug hinges on pricing

Affordability and mass distribution will be critical to the success of a long-lasting injectable HIV prevention drug that has proven highly effective in human trials, say global health specialists.

HIV & AIDS

Sweden meets U.N. targets for combating HIV epidemic: Study

Sweden has reached the UNAIDS and WHO targets for the HIV epidemic, according to a study in Eurosurveillance by researchers at Karolinska Institutet and others. According to the researchers, Sweden is the first country in ...

HIV & AIDS

Sydney's former HIV epicenter close to ending transmission

The inner-city area of Sydney, once the epicenter of Australia's HIV epidemic, is very close to becoming the first place in the world to reach the UN's target for ending transmission of the virus, researchers said on Monday.

HIV & AIDS

'Geneva patient' the latest in long-term remission from HIV

A man dubbed the "Geneva patient" is the latest person with HIV to be declared in long-term remission—however he did not receive a transplant with a virus-blocking gene mutation like previous cases, researchers said on ...

HIV & AIDS

HIV diagnoses in Australia remained low in 2022

Despite disruptions to testing and risk behavior during COVID-19, the latest data from UNSW Sydney's Kirby Institute shows Australia is tracking well toward the elimination of HIV transmission.

Medical research

Researchers solve structure of immune-evading HIV protein complex

The HIV-1 virus can neutralize cellular defenses with its viral infectivity factor (Vif). OIST researchers Prof. Matthias Wolf and Dr. Takahide Kouno together with an international team of colleagues have now determined the ...

HIV & AIDS

'End of AIDS' still possible by 2030: UN

"The end of AIDS" is still possible by 2030, the United Nations insisted Thursday, but cautioned that the world's deadliest pandemic could only be halted if leaders grasped the opportunity.

Medical research

A potential new target to treat HIV infection

Researchers at Johns Hopkins Medicine, in collaboration with researchers at the National Institutes of Health, report that two new studies in mice with a humanized immune system and human cell lines have identified an enzyme ...

HIV & AIDS

International migrants left behind in HIV response: Study

International migrants in Australia and beyond are at increased risk of HIV infection due to reduced access to a highly effective prevention measure, a world-first global review led by Monash University has found.

Medical research

PrEP implant that protects against HIV could be near

Animal research is pointing toward a new way to prevent HIV infection: a refillable implant that continuously delivers antiretroviral medications for up to 20 months at a time.

Medications

Second-line switch to dolutegravir noninferior in HIV

For patients with HIV without genotype information, a second-line switch to dolutegravir is noninferior to a regimen containing a ritonavir-boosted protease inhibitor (PI), according to a study published in the June 22 issue ...

HIV & AIDS

Meningococcal disease cases up in persons with HIV in 2022

In 2022, there was an increase in meningococcal disease among persons with HIV, with 29 cases reported, accounting for 9.8 percent of all meningococcal disease cases, according to research published in the June 16 issue of ...